Also known as: EOMES Gene Sequencing, Neuronal Migration Disorder Panel
Test Price
2,800 AEDโ Home Collection Available
๐ Results in 3โ4 Weeks
EOMES Gene Neuronal Migration Disorder Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic post-test clinical guidance in result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The EOMES gene NGS test screens for pathogenic variants linked to neuronal migration disorders, enabling precise diagnosis and personalized management. This next-generation sequencing identifies mutations in the EOMES gene that can cause microcephaly, polymicrogyria, and related neurodevelopmental conditions.
| Feature | Our Test (EOMES NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 100% coverage, high-depth NGS | Limited to single amplicon, lower sensitivity |
| Method | Next Generation Sequencing (Illumina) | Sanger sequencing |
| Speed | 3โ4 Weeks | 4โ6 Weeks |
Physician Insight & Safety Protocols
"The EOMES gene plays a critical role in neuronal migration during cortical development. Identifying pathogenic variants through high-depth NGS allows clinicians to confirm a diagnosis of microcephaly or polymicrogyria, tailor surveillance protocols, and provide informed genetic counselling to families. A negative result does not exclude all genetic etiologies, and findings must always be correlated with neuroimaging and clinical presentation."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication without consulting your treating physician. Genetic testing is a diagnostic aid and is not a substitute for ongoing medical management or emergency care.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Patients with hemodynamic instability, severe coagulopathy, or inability to provide informed consent are not eligible for home phlebotomy.
- ER Red Flags: Sudden onset of seizures, loss of consciousness, severe headache, or focal neurological deficits demand immediate emergency care โ do not wait for genetic results.
- Important: This test does not replace urgent neuroimaging or acute clinical assessment. Always follow DHA emergency management protocols.
Patient FAQ & Clinical Guidance
1. What is the purpose of this EOMES genetic test?
A: This test identifies disease-causing mutations in the EOMES gene to confirm a diagnosis of neuronal migration disorder and guide treatment. Mutations in EOMES are associated with primary microcephaly, polymicrogyria, and other brain malformations; confirming a variant helps tailor therapy and surveillance.
2. How is the test performed and what sample is required?
A: A trained phlebotomist collects a small blood sample or a drop on an FTA card, which is then processed using high-sensitivity NGS. Whole blood, extracted DNA, or a dry blood spot on an FTA card are all acceptable; our temperature-controlled cold-chain logistics ensure sample stability from your doorstep to the laboratory.
3. Are there any risks or limitations I should know about?
A: This NGS-based genetic test has a diagnostic sensitivity exceeding 99.9% for coding variants, but may not detect deep-intronic or large structural rearrangements. A negative result does not exclude a clinical diagnosis, and incidental findings are handled according to ACMG guidelines. There is no risk beyond routine venipuncture.
UAE Regulatory & Data Privacy Adherence
- Full adherence to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- All home collections are performed by licensed phlebotomists under DHA-approved facility license No. 1143.
- Laboratory operations certified to ISO 9001:2015 (Certificate INT/EGQ/2509DA/3139).
- Genetic counselling is mandated prior to testing to draw a pedigree chart and inform about possible outcomes.
Clinical & Logistical Metadata
| Test Name | EOMES Gene Neuronal Migration Disorder Sequencing |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card Spot |
| Methodology Used | Next-Generation Sequencing (NGS) on Illumina Platform |
| ICD-10-CM Code | Q04.8 |
| LOINC Code | 21636-6 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No specific fasting required", "No medication or diet restrictions"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians